Accedi
logo

The NGF System and its interplay with endocannabinoid signalling, from peripheral sensory terminals to the brain: new targets for the development of next generation drugs for neuropathic pain

Media center

Paincage on the web:

http://www.ebri.it/index.php/en/news-uk2/143-ebri-partneri-in-project-funded-by-the-european-commission-to-fight-pain
http://laboratoriobiologia.sns.it/eu-7fp-project-paincage/?lang=it
http://www.noodls.com/view/570BECA50EC6E8301D8C4CF0C8CF00FA6E9F18DC?8500xxx1400675084
http://www.dicyt.com/noticias/un-proyecto-europeo-busca-nuevos-medicamentos-contra-el-dolor-neuropatico-y-la-osteoartrosis
http://ec.europa.eu/research/health/medical-research/brain-research/projects/paincage_en.html
http://www.levicept.com/news

 

Usefull link:

http://www.dicyt.com/noticias/avance-cientifico-para-modular-la-sensibilidad-al-dolor
http://www.salamancatodonoticias.es/avance-cientifico-modular-sensibilidad-dolor/115140
http://tv.usal.es/videos/1591/investigaci%C3%B3n-sobre-el-dolor-cr%C3%B3nico-y-neurotrofinas

The Project at a glance

Among different forms of chronic pain (CP), neuropathic pain (NP) is a form of neurogenic pain arising from nerve injury in the peripheral or central nervous system, while osteoarthritis (OA) is a progressive degeneration of cartilage of joints and is characterized by inflammation and pain.

Read More →

Facts & Figures

GA n°: 603191
Project type: Collaborative Project
Start date: 01/04/2014
Duration: 36 months then changed to 45 months, with a Project Amendment
Total budget: 7,878 mln €
EC funding: 5,860 mln €

The PAINCAGE Project has received funding from the European Community's Seventh Framework Programme under grant agreement num. 603191

Theme: Health.2013.2.2.1-5 Understanding and controlling pain
Scuola Normale Superiore - Piazza dei Cavalieri, 7 - 56126 Pisa | Codice Fiscale 8000 5050507 | PEC (posta elettronica certificata) protocollo@pec.sns.it